Gilead Sciences, US3755581036

Gilead Sciences stock pre-market at EUR 132.59: minus 0.60 percent

Published on 09/30/2026 at 08:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gilead Sciences stock was at EUR 132.59 in pre-market trading at Lang & Schwarz on September 30, 2026. The price was down 0.60 percent versus the prior close.

Photorealistischer Biotech-Campus von Gilead Sciences mit Glaslabor und Wissenschaftlern
Gilead Sciences Forschungscampus mit ISIN US3755581036 modernes Biopharma-Labor Kalifornien Glasfassade Wissenschaftler arbeiten, Illustration mit AI erstellt.

Gilead Sciences stock was at EUR 132.59 in pre-market trading at Lang & Schwarz at 8:49 a.m. CEST on September 30, 2026. The price was minus 0.60 percent versus the Lang & Schwarz prior close of EUR 133.39 on September 29, 2026.

Pre-market price

The Lang & Schwarz quote had a bid of EUR 132.22 and an ask of EUR 132.96. Xetra had not yet opened for the day.

Recent licensing development

On September 16, Gilead Sciences, Inc. expanded the scope of six royalty-free voluntary licensing agreements for investigational once-yearly lenacapavir for HIV pre-exposure prophylaxis, according to Yahoo Finance.

Disclaimer...

en | US3755581036 | GILEAD SCIENCES | boerse | 70202413 | bgmi